Skip to main content
Photo of  Kenneth Sherman, MD, PhD

Kenneth Sherman, MD, PhD

Professor

COM IM Digestive Diseases Division

Education/Credentials
  • Bachelor's Degree: Rutgers University
  • Doctoral Degree: Rutgers University
  • Medical Degree: George Washington University
  • Research Fellowship : American Red Cross Blood Research Center
  • Residency: Tripler Army Medical Center
  • Fellowship: Fitzsimons Army Medical Center
Board Certifications & Licenses

American Board of Internal Medicine (Gastroenterology) (Certification Date: 02/15/2012)
American Board of Internal Medicine (Certification Date: 09/15/1988)

Clinical Interest

Gastroenterology

Specialties

Gastroenterology
Internal Medicine

Research Interests

Viral Hepatitis - Molecular Heterogeneity, Diagnosis and Treatment, Liver Disease in HIV Infected Patients, Drug Hepatotoxicity.

Contact Information
  • Medical Sciences Building
  • 231 Albert Sabin Way
  • PO Box 670595, ML 0595
  • Cincinnati, Ohio 45267
  • Office 513-558-7200
  • Fax 513-558-6013
  • Email shermake@ucmail.uc.edu

Peer Reviewed Publications

Abdel-Hameed, Enass A; Rouster, Susan D; Kottilil, Shyam; Sherman, Kenneth E 2020. The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Bari, Khurram; Shah, Shimul A; Kaiser, Tiffany E; Cohen, Robert M; Anwar, Nadeem; Kleesattel, David; Sherman, Kenneth E 2020. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a trial. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Butt, Adeel A; Yan, Peng; Aslam, Samia; Abou-Samra, Abdul-Badi; Sherman, Kenneth E; Shaikh, Obaid S 2020. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 3, 664-666

Butt, Adeel A; Yan, Peng; Aslam, Samia; Sherman, Kenneth E; Siraj, Dawd; Safdar, Nasia; Hameed, Bilal 2020. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 92 , 184-188

Butt, Adeel Ajwad; Yan, Peng; Shaikh, Obaid S; Lo Re, Vincent; Abou-Samra, Abdul-Badi; Sherman, Kenneth E 2020. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study. Journal of hepatology, 73 2, 277-284

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Alloway, Rita R; Sherman, Kenneth E 2020. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 75 6, 857-867

Seth, Aradhna; Sherman, Kenneth E 2020. Editorial: HCV Cure is the Start of the End For Those With Advanced Fibrosis/Cirrhosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Seth, Aradhna; Sherman, Kenneth E 2020. Hepatitis E: What We Think We Know. Clinical liver disease, 15 Suppl 1, S37-S44

Sherman, Kenneth E; Abdel-Hameed, Enass A; Ehman, Richard L; Rouster, Susan D; Campa, Adriana; Martinez, Sabrina Sales; Huang, Yongjun; Zarini, Gustavo G; Hernandez, Jacqueline; Teeman, Colby; Tamargo, Javier; Liu, Qingyun; Mandler, Raul; Baum, Marianna K 2020. Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index. Digestive diseases and sciences, 65 4, 1252-1257

Sise, Meghan E; Goldberg, David S; Kort, Jens J; Schaubel, Douglas E; Alloway, Rita R; Durand, Christine M; Fontana, Robert J; Brown, Robert S; Friedewald, John J; Prenner, Stacey; Landis, J Richard; Fernando, Melissa; Phillips, Caitlin C; Woodle, E Steve; Rike-Shields, Adele; Sherman, Kenneth E; Elias, Nahel; Williams, Winfred W; Gustafson, Jenna L; Desai, Niraj M; Barnaba, Brittany; Norman, Silas P; Doshi, Mona; Sultan, Samuel T; Aull, Meredith J; Levitsky, Josh; Belshe, Dianne S; Chung, Raymond T; Reese, Peter P 2020. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. Journal of the American Society of Nephrology : JASN, ,

Zarini, Gustavo; Sales Martinez, Sabrina; Campa, Adriana; Sherman, Kenneth; Tamargo, Javier; Hernandez Boyer, Jacqueline; Teeman, Colby; Johnson, Angelique; Degarege, Abraham; Greer, Pedro; Liu, Qingyun; Huang, Yongjun; Mandler, Raul; Choi, David; Baum, Marianna K 2020. Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort. Journal of women's health (2002), ,

Blackard, Jason T; Kong, Ling; Rouster, Susan D; Karns, Rebekah; Horn, Paul S; Kottilil, Shyam; Shata, M Tarek; Sherman, Kenneth E 2019. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. PloS one, 14 10, e0224523

Blackard, Jason T; Kwara, Awewura; Sherman, Kenneth E 2019. In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of hepatology, 71 6, 1259-1260

Dao, Ann; Cuffy, Madison; Kaiser, Tiffany E; Loethen, Ashley; Cafardi, John; Luckett, Keith; Rike, Adele Helen; Cardi, Michael; Alloway, Rita R; Govil, Amit; Diwan, Tayyab; Sherman, Kenneth E; Shah, Shimul A; Woodle, Ervin Steve 2019. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical transplantation, 33 7, e13598

Eckman, Mark H; Ward, John W; Sherman, Kenneth E 2019. Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17 5, 930-939.e9

Farooq, Priya D; Sherman, Kenneth E 2019. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV. Current HIV/AIDS reports, 16 5, 395-403

Foster, Graham R; Dore, Gregory J; Wang, Stanley; Grebely, Jason; Sherman, Kenneth E; Baumgarten, Axel; Conway, Brian; Jackson, Daniel; Asselah, Tarik; Gschwantler, Michael; Tomasiewicz, Krzysztof; Aguilar, Humberto; Asatryan, Armen; Hu, Yiran; Mensa, Federico J 2019. Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies. Drug and alcohol dependence, 194 , 487-494

Hu, Ke-Qin; Cui, Wei; Rouster, Susan D; Sherman, Kenneth E 2019. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals. World journal of hepatology, 11 5, 442-449

Narayanan, Shivakumar; Abutaleb, Ameer; Sherman, Kenneth E; Kottilil, Shyam 2019. Clinical features and determinants of chronicity in hepatitis E virus infection. Journal of viral hepatitis, 26 4, 414-421

Seth, Aradhna; Sherman, Kenneth E 2019. Fatty liver disease in persons with HIV infection. Topics in antiviral medicine, 27 2, 75-82

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Rouster, Susan D; Yu, Li; Liang, Meina; Song, Esther; Esser, Mark T; Shire, Norah; Sherman, Kenneth E 2019. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathogens & immunity, 4 1, 39-65

Sherman, Kenneth E; Abdel-Hameed, Enass; Rouster, Susan D; Shata, Mohamed Tarek M; Blackard, Jason T; Safaie, Parham; Kroner, Barbara; Preiss, Liliana; Horn, Paul S; Kottilil, Shyam 2019. Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 11, 1911-1918

Sherman, Kenneth E; Peters, Marion G; Thomas, David L 2019. HIV and the liver. Topics in antiviral medicine, 27 3, 101-110

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Aliota, Matthew T; Blackard, Jason T; Dean, Gary E 2019. Zika virus replication and cytopathic effects in liver cells. PloS one, 14 3, e0214016

Abdel-Hameed, Enass A; Rouster, Susan D; Boyce, Ceejay L; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Sherman, Kenneth E 2018. Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients. Digestive diseases and sciences, 63 3, 645-652

Abutaleb, Ameer; Sherman, Kenneth E 2018. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatology international, 12 6, 500-509

Anwar, Nadeem; Sherman, Kenneth E 2018. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical? Journal of viral hepatitis, 25 10, 1110-1115

Bari, Khurram; Luckett, Keith; Kaiser, Tiffany; Diwan, Tayyab; Cuffy, Madison; Schoech, Michael R; Safdar, Kamran; Blackard, Jason T; Apewokin, Senu; Paterno, Flavio; Sherman, Kenneth E; Zucker, Stephen D; Anwar, Nadeem; Shah, Shimul A 2018. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients. Hepatology (Baltimore, Md.), 67 5, 1673-1682

Blackard, Jason T; Sherman, Kenneth E 2018. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Reviews in medical virology, 28 4, e1984

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients. Annals of internal medicine, 169 12, 898-899

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis. Annals of internal medicine, 169 4, 214-223

Rockstroh, Jürgen K; Lacombe, Karine; Viani, Rolando M; Orkin, Chloe; Wyles, David; Luetkemeyer, Anne F; Soto-Malave, Ruth; Flisiak, Robert; Bhagani, Sanjay; Sherman, Kenneth E; Shimonova, Tatiana; Ruane, Peter; Sasadeusz, Joseph; Slim, Jihad; Zhang, Zhenzhen; Samanta, Suvajit; Ng, Teresa I; Gulati, Abhishek; Kosloski, Matthew P; Shulman, Nancy S; Trinh, Roger; Sulkowski, Mark 2018. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67 7, 1010-1017

Safaie, Parham; Razeghi, Sanam; Rouster, Susan D; Privitera, Isaac; Sherman, Kenneth E 2018. Hepatitis D diagnostics:Utilization and testing in the United States. Virus research, 250 , 114-117

Sherman, Kenneth E; Rouster, Susan D; Kang, Minhee; Umbleja, Triin; Sterling, Richard; Butt, Adeel A 2018. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive diseases and sciences, 63 11, 2969-2974

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Shata, Tarek M; Archampong, Timothy; Kwara, Awewura; Aliota, Matthew T; Blackard, Jason T 2018. Zika Virus Exposure in an HIV-Infected Cohort in Ghana. Journal of acquired immune deficiency syndromes (1999), 78 5, e35-e38

Sherman, Kenneth E; Shah, Vijay H 2018. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia. Gastroenterology, 154 3, 453-456

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D 2018. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine, 36 4, 453-460

Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D; Liu, Lin; Li, Eric; Zhao, Lisa; Lim, Joseph K; Morelli, Giuseppe; Kuo, Alexander; Levitsky, Josh; Sherman, Kenneth E; Frazier, Lynn M; Ramani, Ananthakrishnan; Peter, Joy; Akuskevich, Lucy; Fried, Michael W; Nelson, David R 2018. Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Scientific reports, 8 1, 3199

Abdel-Hameed, Enass A; Rouster, Susan D; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Goodman, Zachary D; Sherman, Kenneth E 2017. Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis. Journal of acquired immune deficiency syndromes (1999), 74 3, 353-358

Butt, A A; Ren, Y; Marks, K; Shaikh, O S; Sherman, K E 2017. Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES. Alimentary pharmacology & therapeutics, 45 1, 150-159

Judge, Chelsey J; Kostadinova, Lenche; Sherman, Kenneth E; Butt, Adeel A; Falck-Ytter, Yngve; Funderburg, Nicholas T; Landay, Alan L; Lederman, Michael M; Sieg, Scott F; Sandberg, Johan K; Anthony, Donald D 2017. CD56bright NK IL-7R? expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. Journal of leukocyte biology, 102 1, 171-184

Kiser, Jennifer J; Lu, Darlene; Rosenkranz, Susan L; Morse, Gene D; DiFrancesco, Robin; Sherman, Kenneth E; Butt, Adeel A 2017. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s. Drugs in R&D, 17 4, 557-567

Murrison, Liza Bronner; Sherman, Kenneth E 2017. The Enigma of Hepatitis E Virus. Gastroenterology & hepatology, 13 8, 484-491

Ragni, Margaret V; Humar, Abhinav; Stock, Peter G; Blumberg, Emily A; Eghtesad, Bijan; Fung, John J; Stosor, Valentina; Nissen, Nicholas; Wong, Michael T; Sherman, Kenneth E; Stablein, Donald M; Barin, Burc 2017. Hemophilia Liver Transplantation Observational Study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 23 6, 762-768

Sherman, Kenneth E; Kang, Minhee; Sterling, Richard; Umbleja, Triin; Marks, Kristen; Kiser, Jennifer J; Alston-Smith, Beverly; Greaves, Wayne; Butt, Adeel A; The Actg Birth Study Team, 2017. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World journal of hepatology, 9 4, 217-223

Sherman, Kenneth E; Peters, Marion G; Thomas, David 2017. Human immunodeficiency virus and liver disease: A comprehensive update. Hepatology communications, 1 10, 987-1001

Soriano, Vincent; Sherman, Kenneth E; Barreiro, Pablo 2017. Hepatitis delta and HIV infection. AIDS (London, England), 31 7, 875-884

Abdel-Hameed, Enass A; Rouster, Susan D; Ji, Hong; Ulm, Ashley; Hetta, Helal F; Anwar, Nadeem; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy. Viral immunology, 29 4, 252-8

Blackard, Jason T; Ma, Gang; Polen, Clarissa; DuBois, Juwen C; Gast, Jonathon; Radens, Caleb M; Sterling, Richard K; Sherman, Kenneth E 2016. Recombination among GB virus C (GBV-C) isolates in the United States. The Journal of general virology, 97 7, 1537-1544

Butt, A A; Yan, P; Marks, K; Shaikh, O S; Sherman, K E 2016. Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES. Alimentary pharmacology & therapeutics, 44 7, 728-37

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 9, 1275-83

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 5, 651-8

Campa, Adriana; Martinez, Sabrina Sales; Sherman, Kenneth E; Greer, Joe Pedro; Li, Yinghui; Garcia, Stephanie; Stewart, Tiffanie; Ibrahimou, Boubakari; Williams, O Dale; Baum, Marianna K 2016. Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort. Journal of drug abuse, 2 4,

Feld, Jordan J; Maan, Raoel; Zeuzem, Stefan; Kuo, Alexander; Nelson, David R; Di Bisceglie, Adrian M; Manns, Michael P; Sherman, Ken; Frazier, Lynn M; Sterling, Richard; Mailliard, Mark; Schmidt, Monica; Akushevich, Lucy; Vainorius, Monika; Fried, Michael W 2016. Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63 6, 776-783

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Medhat, Ahmed; Nassar, Mahmoud I; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. Journal of medical microbiology, 65 8, 703-712

Judge, Chelsey J; Sandberg, Johan K; Funderburg, Nicholas T; Sherman, Kenneth E; Butt, Adeel A; Kang, Minhee; Landay, Alan L; Lederman, Michael M; Anthony, Donald D 2016. Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of acquired immune deficiency syndromes (1999), 73 3, 258-262

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E 2016. Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 9, 1066-71

Mehta, Minesh; Hetta, Helal F; Abdel-Hameed, Enass A; Rouster, Susan D; Hossain, MdMonir; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; El-Mokhtar, Mohamed A; Abdelwahab, Sayed F; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. Archives of virology, 161 11, 3161-9

Reau, Nancy; Fried, Michael W; Nelson, David R; Brown, Robert S; Everson, Gregory T; Gordon, Stuart C; Jacobson, Ira M; Lim, Joseph K; Pockros, Paul J; Reddy, K Rajender; Sherman, Kenneth E 2016. HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver international : official journal of the International Association for the Study of the Liver, 36 4, 488-502

Sherman, K E; Ke, R; Rouster, S D; Abdel-Hameed, E A; Park, C; Palascak, J; Perelson, A S 2016. Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 22 4, 543-8

Butt, A A; Yan, P; Shaikh, O S; Freiberg, M S; Lo Re, V; Justice, A C; Sherman, K E 2015. Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings. Journal of viral hepatitis, 22 9, 691-700

Butt, Adeel A; Yan, Peng; Lo Re, Vincent; Rimland, David; Goetz, Matthew B; Leaf, David; Freiberg, Matthew S; Klein, Marina B; Justice, Amy C; Sherman, Kenneth E 2015. Liver fibrosis progression in hepatitis C virus infection after seroconversion. JAMA internal medicine, 175 2, 178-85

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Nassar, Mahmoud I; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2015. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. Journal of gastroenterology and hepatology, 30 10, 1543-51

Jensen, Donald; Sherman, Kenneth E; Hézode, Christophe; Pol, Stanislas; Zeuzem, Stefan; de Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong; Bernstein, David; McPhee, Fiona; Hennicken, Delphine; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie 2015. Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders. Journal of hepatology, 63 1, 30-7

Sherman, Kenneth E; Rockstroh, Juergen; Thomas, David 2015. Human immunodeficiency virus and liver disease: An update. Hepatology (Baltimore, Md.), 62 6, 1871-82

Shire, Norah J; Sherman, Kenneth E 2015. Epidemiology of Hepatitis C Virus: A Battle on New Frontiers. Gastroenterology clinics of North America, 44 4, 699-716

Wyles, David L; Ruane, Peter J; Sulkowski, Mark S; Dieterich, Douglas; Luetkemeyer, Anne; Morgan, Timothy R; Sherman, Kenneth E; Dretler, Robin; Fishbein, Dawn; Gathe, Joseph C; Henn, Sarah; Hinestrosa, Federico; Huynh, Charles; McDonald, Cheryl; Mills, Anthony; Overton, Edgar Turner; Ramgopal, Moti; Rashbaum, Bruce; Ray, Graham; Scarsella, Anthony; Yozviak, Joseph; McPhee, Fiona; Liu, Zhaohui; Hughes, Eric; Yin, Philip D; Noviello, Stephanie; Ackerman, Peter 2015. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. The New England journal of medicine, 373 8, 714-25

Abdel-Hameed, Enass A; Ji, Hong; Sherman, Kenneth E; Shata, Mohamed T M 2014. Epigenetic modification of FOXP3 in patients with chronic HIV infection. Journal of acquired immune deficiency syndromes (1999), 65 1, 19-26

Anwar, Nadeem; Sherman, Kenneth E 2014. HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure. Clinical liver disease, 4 4, 80-83

Blackard, Jason T; Ma, Gang; Sengupta, Satarupa; Martin, Christina M; Powell, Eleanor A; Shata, M Tarek; Sherman, Kenneth E 2014. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. Journal of medical virology, 86 8, 1332-41

Lin, M V; Charlton, A N; Rouster, S D; Zamor, P J; Sherman, K E 2014. Hepatitis C virus NS3 mutations in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 20 5, 659-65

Schmidt, Warren N; Nelson, David R; Pawlotsky, Jean-Michel; Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2014. Direct-acting antiviral agents and the path to interferon independence. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 12 5, 728-37

Sherman, K E; Terrault, N; Barin, B; Rouster, S D; Shata, M T 2014. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. Journal of viral hepatitis, 21 8, e74-7

Sherman, Kenneth E; Guedj, Jeremie; Shata, Mohamed Tarek; Blackard, Jason T; Rouster, Susan D; Castro, Mario; Feinberg, Judith; Sterling, Richard K; Goodman, Zachary; Aronow, Bruce J; Perelson, Alan S 2014. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science translational medicine, 6 246, 246ra98

Sherman, Kenneth E; Thomas, David; Chung, Raymond T 2014. Human immunodeficiency virus and liver disease forum 2012. Hepatology (Baltimore, Md.), 59 1, 307-17

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Hetta, Helal F; Sherman, Kenneth E 2013. Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). Journal of clinical pathology, 66 11, 967-75

Blackard, Jason T; Ma, Gang; Welge, Jeffrey A; Martin, Christina M; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J 2012. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. Journal of medical virology, 84 2, 242-52

Jennings, Carrie L; Sherman, Kenneth E 2012. Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Current HIV/AIDS reports, 9 3, 231-7

Kemmer, N; Hua, L; Andersen, J W; Chung, R T; Butt, A A; Sherman, K E 2012. Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. Journal of viral hepatitis, 19 11, 792-800

Kong, Ling; Cardona Maya, Walter; Moreno-Fernandez, Maria E; Ma, Gang; Shata, Mohamed T; Sherman, Kenneth E; Chougnet, Claire; Blackard, Jason T 2012. Low-level HIV infection of hepatocytes. Virology journal, 9 , 157

Martin, C M; Welge, J A; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2012. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. Journal of viral hepatitis, 19 10, 716-23

Shata, Mohamed T; Daef, Enas A; Zaki, Maysaa E; Abdelwahab, Sayed F; Marzuuk, Naglaa M; Sobhy, Maha; Rafaat, Marwa; Abdelbaki, Liala; Nafeh, Mohamed A; Hashem, Mohamed; El-Kamary, Samer S; Shardell, Michelle D; Mikhail, Nabiel N; Strickland, George T; Sherman, Kenneth E 2012. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106 10, 613-8

Sherman, Kenneth E 2012. Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 9, 1236-41

Blackard, Jason T; Ma, Gang; Martin, Christina M; Rouster, Susan D; Shata, M Tarek; Sherman, Kenneth E 2011. HIV Variability in the Liver and Evidence of Possible Compartmentalization. AIDS research and human retroviruses, ,

Blackard, Jason T; Welge, Jeffrey A; Taylor, Lynn E; Mayer, Kenneth H; Klein, Robert S; Celentano, David D; Jamieson, Denise J; Gardner, Lytt; Sherman, Kenneth E 2011. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 5, 674-80

Eckman, Mark H; Kaiser, Tiffany E; Sherman, Kenneth E 2011. The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 11, 1294-306

Hernandez, Maria D; Sherman, Kenneth E 2011. HIV/hepatitis C coinfection natural history and disease progression. Current opinion in HIV and AIDS, 6 6, 478-82

Kemmer, Nyingi M; Sherman, Kenneth E 2011. Liver transplantation trends in the HIV population. Digestive diseases and sciences, 56 11, 3393-8

Sherman, Kenneth E 2011. Hepatitis e virus infection: more common than previously realized? Gastroenterology & hepatology, 7 11, 759-61

Sherman, Kenneth E; Flamm, Steven L; Afdhal, Nezam H; Nelson, David R; Sulkowski, Mark S; Everson, Gregory T; Fried, Michael W; Adler, Michael; Reesink, Hendrik W; Martin, Marie; Sankoh, Abdul J; Adda, Nathalie; Kauffman, Robert S; George, Shelley; Wright, Christopher I; Poordad, Fred 2011. Response-guided telaprevir combination treatment for hepatitis C virus infection. The New England journal of medicine, 365 11, 1014-24

Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2011. Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology (Baltimore, Md.), 54 6, 2245-53

Taylor, Lynn E; Holubar, Marisa; Wu, Kunling; Bosch, Ronald J; Wyles, David L; Davis, John A; Mayer, Kenneth H; Sherman, Kenneth E; Tashima, Karen T 2011. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 6, 812-8

Blackard, Jason T; Ma, Gang; Limketkai, Berkeley N; Welge, Jeffrey A; Dryer, Peter D; Martin, Christina M; Hiasa, Yoichi; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Sherman, Kenneth E 2010. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. Journal of clinical microbiology, 48 11, 4256-9

Kemmer, Nyingi M; Sherman, Kenneth E 2010. Hepatitis C-related arthropathy: Diagnostic and treatment considerations. The Journal of musculoskeletal medicine, 27 9, 351-354

Martin, C M; Welge, J A; Shire, N J; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2010. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Journal of viral hepatitis, 17 8, 588-97

McHutchison, John; Goodman, Zachary; Patel, Keyur; Makhlouf, Hala; Rodriguez-Torres, Maribel; Shiffman, Mitchell; Rockey, Don; Husa, Petr; Chuang, Wan-Long; Levine, Robert; Jonas, Mark; Theodore, Dickens; Brigandi, Richard; Webster, Alison; Schultz, Margaret; Watson, Helen; Stancil, Britt; Gardner, Stephen 2010. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology, 138 4, 1365-73, 1373.e1-2

Rashkin, S; Rouster, S; Goodman, Z D; Sherman, K E 2010. T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients. Journal of viral hepatitis, 17 3, 222-6

Schmeltzer, Paul; Sherman, Kenneth E 2010. Occult hepatitis B: clinical implications and treatment decisions. Digestive diseases and sciences, 55 12, 3328-35

Sherman, Kenneth E 2010. Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences, 1194 , 136-40

Sherman, Kenneth E; Andersen, Janet W; Butt, Adeel A; Umbleja, Triin; Alston, Beverly; Koziel, Margaret J; Peters, Marion G; Sulkowski, Mark; Goodman, Zachary D; Chung, Raymond T 2010. Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). Journal of acquired immune deficiency syndromes (1999), ,

Sherman, Kenneth E; Rouster, Susan D; Stanford, Sandra; Blackard, Jason T; Shire, Norah; Koziel, Margaret; Peters, Marion; Chung, Raymond T 2010. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. The Journal of infectious diseases, 201 5, 712-9

Sherman, Kenneth E; Soriano, Vincent; Chung, Raymond T 2010. Human immunodeficiency virus and liver disease: conference proceedings. Hepatology (Baltimore, Md.), 51 3, 1046-54

Sulkowski, Mark S; Shiffman, Mitchell L; Afdhal, Nezam H; Reddy, K Rajender; McCone, Jonathan; Lee, William M; Herrine, Steven K; Harrison, Stephen A; Poordad, F Fred; Koury, Kenneth; Deng, Weiping; Noviello, Stephanie; Pedicone, Lisa D; Brass, Clifford A; Albrecht, Janice K; McHutchison, John G 2010. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology, 139 5, 1602-11, 1611.e1

Atiq, Muslim; Shire, Norah J; Barrett, Anna; Rouster, Susan D; Sherman, Kenneth E; Shata, Mohamed T 2009. Hepatitis E virus antibodies in patients with chronic liver disease. Emerging infectious diseases, 15 3, 479-81

Blackard, Jason T; Rouster, Susan D; Nady, Soad; Galal, Gehan; Marzuuk, Naglaa; Rafaat, Marwaa M; Daef, Enas; El Din, Salwa Seif; Purcell, Robert H; Emerson, Suzanne U; Sherman, Kenneth E; Shata, M Tarek 2009. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 46 2, 140-4

Dryer, Peter D; Limketkai, Berkeley N; Martin, Christina M; Ma, Gang; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Blackard, Jason T 2009. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. The Journal of antimicrobial chemotherapy, 64 5, 945-8

Gordon, Stuart C; Sherman, Kenneth E 2009. Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology, 136 2, 393-6

Martin, Christina M; Welge, Jeffrey A; Shire, Norah J; Shata, Mohamed T; Sherman, Kenneth E; Blackard, Jason T 2009. Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine, 47 3, 194-8

Poynard, Thierry; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Bedossa, Pierre; Mukhopadhyay, Pabak; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice 2009. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology, 136 5, 1618-28.e2

Sherman, Kenneth; Belkin, Igor M; Friedland, Kevin D; O'Reilly, John; Hyde, Kimberly 2009. Accelerated warming and emergent trends in fisheries biomass yields of the world's large marine ecosystems. Ambio, 38 4, 215-24

Shire, Norah J; Rao, Marepalli B; Succop, Paul; Buncher, C Ralph; Andersen, Janet A; Butt, Adeel A; Chung, Raymond T; Sherman, Kenneth E 2009. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 4, 471-80, 480.e1-2

Blackard, J T; Sherman, K E 2008. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? Journal of viral hepatitis, 15 5, 323-30

Blackard, Jason T; Shata, M Tarek; Shire, Norah J; Sherman, Kenneth E 2008. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, Md.), 47 1, 321-31

Dichiara, A J; Atkinson, M; Goodman, Z; Sherman, K E 2008. Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva gastroenterologica e dietologica, 54 3, 307-15

Kemmer, Nyingi; Sherman, Kenneth E 2008. What is the impact of HIV infection on survival after liver transplantation? Nature clinical practice. Gastroenterology & hepatology, 5 8, 426-7

Alatrakchi, Nadia; Graham, Camilla S; van der Vliet, Hans J J; Sherman, Kenneth E; Exley, Mark A; Koziel, Margaret James 2007. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. Journal of virology, 81 11, 5882-92

Blackard, Jason T; Kang, Minhee; St Clair, J Benjamin; Lin, Wenyu; Kamegaya, Yoshitaka; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Andersen, Janet; Chung, Raymond T 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 27 4, 263-9

Blackard, Jason T; Sherman, Kenneth E 2007. Hepatitis C virus coinfection and superinfection. The Journal of infectious diseases, 195 4, 519-24

Shata, M T; Barrett, A; Shire, N J; Abdelwahab, S F; Sobhy, M; Daef, E; El-Kamary, S S; Hashem, M; Engle, R E; Purcell, R H; Emerson, S U; Strickland, G T; Sherman, K E 2007. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. Journal of immunological methods, 328 1-2, 152-61

Sherman, Kenneth E 2007. New paradigms in the management of hepatitis C virus co-infections. Nature clinical practice. Gastroenterology & hepatology, 4 Suppl 1 , S10-6

Sherman, Kenneth E; Fleischer, Russell; Laessig, Katherine; Murray, Jeffrey; Tauber, William; Birnkrant, Debra 2007. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations. Hepatology (Baltimore, Md.), 46 6, 2014-20

Sherman, Kenneth E; Goodman, Zachary D; Sullivan, Sara T; Faris-Young, Sima 2007. Liver biopsy in cirrhotic patients. The American journal of gastroenterology, 102 4, 789-93

Sherman, Kenneth E; Peters, Marion; Koziel, Margaret James 2007. HIV and liver disease forum: conference proceedings. Hepatology (Baltimore, Md.), 45 6, 1566-77

Shire, N J; Welge, J A; Sherman, K E 2007. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis. Journal of viral hepatitis, 14 4, 239-48

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E 2007. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 44 3, 309-14

Atiq, Muslim; Neff, Guy W; Buell, Joseph; Kemmer, Nyingi; Rudich, Steven; Weber, Fred; Sherman, Kenneth 2006. Rhabdomylysis transference during liver transplantation. Transplantation, 81 9, 1359-60

Blackard, Jason T; Kang, Minhee; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Chung, Raymond T 2006. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 26 11, 834-8

Blackard, Jason T; Kemmer, Nyingi; Sherman, Kenneth E 2006. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (Baltimore, Md.), 44 1, 15-22

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2006. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS (London, England), 20 3, 345-51

Mandac, Jamie C; Chaudhry, Sonal; Sherman, Kenneth E; Tomer, Yaron 2006. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore, Md.), 43 4, 661-72

Mann, Elizabeth A; Stanford, Sandra; Sherman, Kenneth E 2006. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus research, 121 1, 51-7

Mrus, Joseph M; Sherman, Kenneth E; Leonard, Anthony C; Sherman, Susan N; Mandell, Karen L; Tsevat, Joel 2006. Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Medical care, 44 2, 158-66

Neff, Guy W; Jayaweera, Dushyantha; Sherman, Kenneth E 2006. Drug-Induced Liver Injury in HIV Patients. Gastroenterology & hepatology, 2 6, 430-437

Peters, Marion G; Andersen, Janet; Lynch, Patrick; Liu, Tun; Alston-Smith, Beverly; Brosgart, Carol L; Jacobson, Jeffrey M; Johnson, Victoria A; Pollard, Richard B; Rooney, James F; Sherman, Kenneth E; Swindells, Susan; Polsky, Bruce 2006. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (Baltimore, Md.), 44 5, 1110-6

Schwarze-Zander, Carolynne; Blackard, Jason T; Zheng, Hui; Addo, Marylyn M; Lin, Wenyu; Robbins, Gregory K; Sherman, Kenneth E; Zdunek, Dietmar; Hess, Georg; Chung, Raymond T 2006. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. The Journal of infectious diseases, 194 4, 410-9

Shire, N J; Sherman, K E 2006. Management of hepatitis B virus in HIV-positive patients. Minerva gastroenterologica e dietologica, 52 1, 67-87

Shire, Norah J; Horn, Paul S; Rouster, Susan D; Stanford, Sandra; Eyster, M Elaine; Sherman, Kenneth E 2006. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology (Baltimore, Md.), 44 5, 1146-57

Shire, Norah J; Welge, Jeffrey A; Sherman, Kenneth E 2006. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine, 24 3, 272-9

Alatrakchi, Nadia; Graham, Camilla S; He, Qi; Sherman, Kenneth E; Koziel, Margaret James 2005. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. The Journal of infectious diseases, 191 5, 702-9

Chun, Sooyun; Sherman, Kenneth E 2005. Treatment of hepatitis C virus/HIV coinfection. Clinics in liver disease, 9 3, 525-33, ix

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E 2005. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. The Journal of infectious diseases, 191 5, 686-93

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2005. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (London, England), 19 8, 767-73

Lienesch, Douglas; Morris, Robert; Metzger, Allan; Debuys, Paige; Sherman, Kenneth 2005. Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. The Journal of rheumatology, 32 3, 489-93

Qin, Hongxing; Shire, Norah J; Keenan, Erica D; Rouster, Susan D; Eyster, M Elaine; Goedert, James J; Koziel, Margaret James; Sherman, Kenneth E 2005. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood, 105 2, 533-41

Sherman, Kenneth E 2005. Treatment of hepatitis C virus and human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 10 Suppl 2, S118-21

Sherman, Kenneth E; Shire, Norah J; Cernohous, Paul; Rouster, Susan D; Omachi, Janice H; Brun, Scott; Da Silva, Barbara 2005. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 8, 1186-95

Sherman, Kenneth E; Shire, Norah J; Rouster, Susan D; Peters, Marion G; James Koziel, Margaret; Chung, Raymond T; Horn, Paul S 2005. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology, 128 2, 313-27

Shire, Norah J; Sherman, Kenneth E 2005. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 Suppl 1 , S63-8

Shire, Norah J; Sherman, Kenneth E 2005. Management of HBV/HIV-coinfected Patients. Seminars in liver disease, 25 Suppl 1 , 48-57

Blackard, Jason T; Yang, Yijun; Bordoni, Paola; Sherman, Kenneth E; Chung, Raymond T 2004. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. The Journal of infectious diseases, 189 8, 1472-81

Chung, Raymond T; Andersen, Janet; Volberding, Paul; Robbins, Gregory K; Liu, Tun; Sherman, Kenneth E; Peters, Marion G; Koziel, Margaret J; Bhan, Atul K; Alston, Beverly; Colquhoun, Dodi; Nevin, Tom; Harb, George; van der Horst, Charles 2004. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. The New England journal of medicine, 351 5, 451-9

Fleischer, Russell; Boxwell, Debra; Sherman, Kenneth E 2004. Nucleoside analogues and mitochondrial toxicity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38 8, e79-80

Graham, Camilla S; Curry, Michael; He, Qi; Afdhal, Nezam; Nunes, David; Fleming, Catherine; Horsburgh, Robert; Craven, Donald; Sherman, Kenneth E; Koziel, Margaret James 2004. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (Baltimore, Md.), 40 1, 125-32

Keenan, Erica D; Rouster, Susan D; Shire, Norah J; Horn, Paul S; Sherman, Kenneth E 2004. Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. The Journal of infectious diseases, 190 3, 511-4

Morelli, Michael S; Rouster, Susan D; Giannella, Ralph A; Sherman, Kenneth E 2004. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2 8, 669-74

Neff, G W; Sherman, K E; Eghtesad, B; Fung, J 2004. Review article: current status of liver transplantation in HIV-infected patients. Alimentary pharmacology & therapeutics, 20 10, 993-1000

Sherman, Kenneth E 2004. HCV and HIV: a tale of two viruses. Reviews in gastroenterological disorders, 4 Suppl 1 , S48-54

Sherman, Kenneth E; Sherman, Susan N; Chenier, Thomas; Tsevat, Joel 2004. Health values of patients with chronic hepatitis C infection. Archives of internal medicine, 164 21, 2377-82

Shire, Norah J; Rouster, Susan D; Rajicic, Natasa; Sherman, Kenneth E 2004. Occult hepatitis B in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 36 3, 869-75

Zucker, Stephen D; Horn, Paul S; Sherman, Kenneth E 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (Baltimore, Md.), 40 4, 827-35

Zucker, Stephen D; Sherman, Kenneth E 2004. Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology, 126 5, 1487-8

Keiserman, Daniela R; Both, Cristiane T; Mattos, Angelo A; Remiao, Jose; Alexandre, Claudio O P; Sherman, Kenneth E 2003. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. The American journal of gastroenterology, 98 4, 878-83

Sherman, Kenneth E 2003. Implications of peginterferon use in special populations infected with HCV. Seminars in liver disease, 23 Suppl 1 , 47-52

Shiramizu, Bruce; Theodore, Dickens; Bassett, Roland; Coel, Marc; Sherman, Kenneth E; Glesby, Marshall J; Chow, Dominic; Alston, Beverly; Colquhoun, Dodi; Merigan, Thomas C; Reichman, Richard C; Berggren, Ruth; Burning, Wendy Jo; Brobst, Susan 2003. Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. Journal of acquired immune deficiency syndromes (1999), 33 3, 329-35

Ajayi, Thomas; Sherman, Kenneth; Tang, Qisheng 2002. Support of marine sustainability science. Science (New York, N.Y.), 297 5582, 772

Bleau, Brian L; Gostout, Christopher J; Sherman, Kenneth E; Shaw, Michael J; Harford, William V; Keate, Ray F; Bracy, Waldo P; Fleischer, David E 2002. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal endoscopy, 56 1, 1-6

Chung, Raymond T; Evans, Scott R; Yang, Yijun; Theodore, Dickens; Valdez, Hernan; Clark, Rebecca; Shikuma, Cecilia; Nevin, Thomas; Sherman, Kenneth E 2002. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS (London, England), 16 14, 1915-23

Goedert, James J; Eyster, M Elaine; Lederman, Michael M; Mandalaki, Titica; De Moerloose, Philippe; White, Gilbert C; Angiolillo, Anne L; Luban, Naomi L C; Sherman, Kenneth E; Manco-Johnson, Marilyn; Preiss, Liliana; Leissinger, Cindy; Kessler, Craig M; Cohen, Alan R; DiMichele, Donna; Hilgartner, Margaret W; Aledort, Louis M; Kroner, Barbara L; Rosenberg, Philip S; Hatzakis, Angelos 2002. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood, 100 5, 1584-9

Sherman, Kenneth E 2002. Diagnosis and management of the HCV/HIV-coinfected patient. AIDS clinical care, 14 5, 39-43, 48

Sherman, Kenneth E; Rouster, Susan D; Chung, Raymond T; Rajicic, Natasa 2002. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 6, 831-7

Sherman, Kenneth E; Rouster, Susan D; Horn, Paul S 2002. Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 35 4, 482-7

Sherman, K E; Rouster, S D; Feinberg, J 2001. Prevalence and genotypic variability of TTV in HIV-infected patients. Digestive diseases and sciences, 46 11, 2401-7

Zucker, S D; Qin, X; Rouster, S D; Yu, F; Green, R M; Keshavan, P; Feinberg, J; Sherman, K E 2001. Mechanism of indinavir-induced hyperbilirubinemia. Proceedings of the National Academy of Sciences of the United States of America, 98 22, 12671-6

Manocha, A P; Sossenheimer, M; Martin, S P; Sherman, K E; Venkatesan, T; Whitcomb, D C; Ulrich, C D 1999. Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). The American journal of gastroenterology, 94 3, 784-9

Mendenhall, C L; Finkelman, F; Means, R T; Sherman, K E; Nguyen, V T; Grossman, C E; Morris, S C; Rouster, S; Roselle, G A 1999. Cytokine response to BCG infection in alcohol-fed mice. Alcohol (Fayetteville, N.Y.), 19 1, 57-63

Sherman, K E; Rouster, S D; Mendenhall, C; Thee, D 1999. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology (Baltimore, Md.), 30 1, 265-70

Sherman, K E; Sickler, J; Aranda-Michel, J; Weber, F L; Martin, S; Whiting, J; Hanto, D 1999. Rimantadine for treatment of hepatitis C infection in liver transplant recipients. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 5 1, 25-8

Aranda-Michel, J; Sherman, K E 1998. Tests of the liver: use and misuse. The Gastroenterologist, 6 1, 34-43

Sherman, K E; Sjogren, M; Creager, R L; Damiano, M A; Freeman, S; Lewey, S; Davis, D; Root, S; Weber, F L; Ishak, K G; Goodman, Z D 1998. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology (Baltimore, Md.), 27 4, 1128-35

Sickler, J B; Simmons, R A; Cobb, D K; Sherman, K E 1998. Cutaneous necrosis associated with interferon alpha-2b. The American journal of gastroenterology, 93 3, 463-4

Sherman, K E; Mendenhall, C; Thee, D L; O'Brien, J; Rouster, S D 1997. Hepatitis C serotypes in nonalcoholic and alcoholic patients. Digestive diseases and sciences, 42 11, 2285-91

Jain, R; McLaren, B; Bejarano, P; Sherman, K E 1996. A 69-year-old man with cholestatic liver disease. Seminars in liver disease, 16 4, 445-9

Sherman, K E; Andreatta, C; O'Brien, J; Gutierrez, A; Harris, R 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology (Baltimore, Md.), 23 4, 688-94

Sherman, K E; Lewey, S M; Goodman, Z D 1995. Talc in the liver of patients with chronic hepatitis C infection. The American journal of gastroenterology, 90 12, 2164-6

Acquavita, Shauna P; Kauffman, Sandra S; Talks, Alexandra; Sherman, Kate . Pregnant women with substance use disorders: The intersection of history, ethics, and advocacy. Social work in health care, 55 10, 843-860

Lienesch, D W; Sherman, K E; Metzger, A; Shen, G Q . Anti-Clq antibodies in patients with chronic hepatitis C infection. Clinical and experimental rheumatology, 24 2, 183-5

Meyer, C A; White, C S; Sherman, K E . Diseases of the hepatopulmonary axis. Radiographics : a review publication of the Radiological Society of North America, Inc, 20 3, 687-98

Sherman, Kenneth E . Management of the Hepatitis B Virus/HIV-Coinfected Patient. Topics in antiviral medicine, 23 3, 111-4

Sherman, Kenneth E . Managing adverse effects and complications in completing treatment for hepatitis C virus infection. Topics in antiviral medicine, 20 4, 125-8

Sherman, Kenneth E . Advanced liver disease: what every hepatitis C virus treater should know. Topics in antiviral medicine, 19 3, 121-5

Directory Search

Contact Us

Department of Anesthesiology

Medical Sciences Building
Room 3502
231 Albert Sabin Way
PO Box 670531
Cincinnati, OH 45267-0531

Mail Location: 0531
Phone: 513-558-2402
Fax: 513-558-0995
Email: mcclanpa@ucmail.uc.edu